Biological Systems
Enzyme-enabled biological transformation and selective molecular conversion.

01 / Technology
Enviraxyme translates advanced scientific capabilities into technology platforms for resource recovery.
Our role is to integrate complementary technologies, validate how they work together and develop pathways from scientific opportunity toward practical application.
Science gives us the possibility.
Technology integration makes it usable.
Translation moves it toward application.
02 / The technology platform
Enviraxyme works at the interface of complementary scientific and technological capabilities rather than treating any single technology as the solution.
We integrate and translate these capabilities into configurations designed around defined resource-recovery challenges.
Enzyme-enabled biological transformation and selective molecular conversion.
Nanomaterials and material interfaces designed to support interaction, stability, separation or recovery.
Combining biological and material capabilities into functional technology configurations.
Moving validated technology configurations toward practical process concepts and meaningful scale.
03 / How we translate science
Identify a promising scientific capability relevant to a resource-recovery challenge.
Bring complementary biological, material and process capabilities together.
Test whether the integrated technology performs the intended function.
Develop the technology around a defined resource-recovery challenge.
Develop the pathway toward practical implementation and meaningful scale.
04 / Lead technology programme
01 / PET Circularity
Enviraxyme is developing an enzyme–nanomaterial technology platform for PET depolymerisation, with the objective of recovering useful molecular building blocks from PET waste.
Lead Programme — In Development
The programme is focused on translating an integrated technology concept toward functional validation and practical application. Recovered building blocks may include terephthalic acid (TPA) and ethylene glycol (EG). Commercial readiness is not implied.
05 / Emerging technology direction
02 / Materials Recovery
Enviraxyme is also exploring technology pathways for the recovery of valuable materials from complex resource streams.
Materials recovery, including rare-earth-element recovery, is an emerging research direction at an earlier stage of maturity than the PET programme.
Emerging Programme — Research & Development
06 / From technology to process
Scientific performance is only one part of translation. Enviraxyme works toward integrating validated technology into process concepts that can ultimately operate at meaningful scale.
Conceptual pathway — not a claim of current industrial deployment
07 / The translation layer
Scientific capabilities can exist across institutions, disciplines and technology partners. Enviraxyme brings complementary capabilities together around defined resource-recovery challenges.
Enviraxyme is the technology integration and translation layer — not a university, research laboratory or pure technology licensor.
08 / Work with Enviraxyme
We work with scientific institutions, technology partners, industrial organisations and investors to translate promising science into practical technologies.